News

ctic front page

CTIC Capital宣布将举行第二届年度跨境中美医疗投资峰会

云集150多位中国医疗投资者的第二届年度 CTIC Capital 跨境医疗投资峰会将于2018年1月7日(周日)在旧金山凯悦酒店举行。届时,2013年诺贝尔理学与医学奖得主、加州大学伯克利分校分子与细胞生物学教授兰迪-谢克曼将发表主题演讲。 加州帕洛阿尔托2018年1月4日电…
novocure-7x4

Novocure brings Optune tech to drug trial for glioblastoma

Novocure (NSDQ:NVCR) said today that it joined a Phase Ib study to evaluate the safety of Celgene‘s (NSDQ:CELG) marizomib and temozolomide in combination with Optune for patients with newly-diagnosed glioblastoma. The trial is the first…
BrendanFrey2_DeepGenomics_credit-Johnny-Guatto_600x400

Deep Genomics Shifts Focus to Genetic Medicines

By Allison Proffitt  May 12, 2017 | In August 2015 when Deep Genomics first launched, co-founder Brendan Frey made a prediction. “There’s a sea change coming,” he told Bio-IT World. “People are going to be focusing now on the machine…
Tencent Holdings Ltd.'s new headquarters stand under construction in Shenzhen, China, on Monday, Aug. 22, 2016. The new headquarters for Tencent is a $599 million project aimed at creating a campus-like atmosphere for the urban setting. Scheduled for completion next year, the Shenzhen skyscraper could become one of the largest labs for new internet services and connected devices. Photographer: Qilai Shen/Bloomberg via Getty Images

Tencent increases its focus on artificial intelligence

When it comes to artificial intelligence (AI) and Chinese tech companies, thoughts often begin and end with Baidu. But Tencent, Asia’s second highest-valued tech company behind Alibaba, has reminded the world that it too is investing in the…
editas

Editas, Allergan Ink $90M CRISPR-Based Eye Drug Deal

NEW YORK (GenomeWeb) – Editas Medicine has signed a deal potentially worth more than $90 million, giving Allergan the exclusive rights to license certain of its CRISPR genome editing-based treatments for eye diseases. Under the terms of…
freenome

Freenome Raises $65M in Series A Funds

NEW YORK (GenomeWeb) – Palo Alto, California-based Freenome announced today that it has raised $65 million in Series A funding, which it will put toward conducting clinical trials to validate its non-invasive, early cancer detection technology. The…
26CHIMERA3-superJumbo-v2

New prospects for growing human replacement organs in animals

For the first time, biologists have succeeded in growing human stem cells in animal embryos, shifting from science fiction to the realm of the possible the idea of developing human organs in animals for later transplant. The approach involves…
Hands_2

Digital Addiction Therapy Could Be First FDA-Approved App

LAS VEGAS — Digital therapy could soon be prescribed and reimbursed like a pharmaceutical drug for patients with chronic substance use disorder. "This could be a watershed moment for digital health," said Corey McCann, MD, PhD, chief executive…
17YAMANAKA-master768

The Stem-Cell Revolution Is Coming — Slowly

 Shinya Yamanaka directs Kyoto University’s Center for iPS Cell Research and Application, and leads a small research lab at the Gladstone Institutes, which is affiliated with the University of California, San Francisco. In…